Global Hematopoietic Stem Cell Transplantation (HSCT) Market: Snapshot
The global market hematopoietic stem cell transplantation (HSCT) has been witnessing a high rise in its valuation and size over the last few years and is anticipated to remain doing so over the next few years. The considerable rise in the geriatric population and the increasing prevalence of non-communicable diseases is the key driving force behind the growth of this market. The increasing life expectancy, growing income, and the escalating government expenditure on health care, free trade agreement, and continuous research and development are other prominent factors, boosting the demand for HSCT across the world.
Over the coming years, the worldwide HSCT market is expected to gain substantially from the continual research and development to provide innovative drugs and treatment for a host of diseases. In terms of opportunity, the market is estimated to increase at a CAGR of 12.80% from 2017 to 2025, rising from a value of US$13.06 bn in 2016 to US$37.61 bn by the end of 2025.
Europe to Continue Leading Global Hematopoietic Stem Cell Transplantation (HSCT) Market
On the basis of geography, the global hematopoietic stem cell transplantation market is classified into North America, Latin America, the Middle East and Africa, Europe, and Asia Pacific. Among these, Europe and North America have been leading the global market with a large population size, increase in health expenditure, and the presence of a state-of-art medical and healthcare infrastructure. Europe holds the dominant position in the global market and is anticipated to remain on the top over the next few years on account of the rising prevalence of hematological as well as non-hematological disorders.
The second position in the global HSCT market has been acquired by North America. The presence of a well-established medical and healthcare industry, increasing investments for research and development, introduction of improved and technologically advanced hematopoietic stem cells transplantation services on regular intervals, and the high gross domestic product (GDP) of countries in this region are some of the key factors behind the rise of the North America HSCT market.
Allogeneic Transplants to Dominate Global Market
Based on the type of transplant, the worldwide market for hematopoietic stem cell transplantation (HSCT) has been categorized into allogeneic transplants and autologous transplants. The allogeneic transplants segment has been leading this market and is expected to continue on the top over the next few years. Allogeneic transplants are of two types: Family related and unrelated transplant.
The increasing number of donors and post-transplant survival rates are likely to drive this segment in the years to come. The autologous segment, on the other hand, is anticipated to grow steadily over the forthcoming years on account of the usage of autologous transplants as the standard of care for multiple myeloma (MM) patients.
Regen Biopharma Inc., Escape Therapeutics Inc., Cryo-Save AG, Lonza Group Ltd., Pluristem Therapeutics Inc., China Cord Blood Corp., CBR Systems Inc., and ViaCord Inc. are the leading players operating in the global market for hematopoietic stem cell transplantation (HSCT).
Global Hematopoietic Stem Cell Transplantation (HSCT) Market: Overview
This report on Hematopoietic Stem Cell Transplantation (HSCT) market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of HSCT as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global HSCT market with respect to the leading market segments based on transplants types, disease indication, applications and geographies.
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global hematopoietic stem cell transplantation (HSCT) market and could influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the market across different transplants/disease indication/applications/geographies. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.
Global Hematopoietic Stem Cell Transplantation (HSCT) Market: Segmentation
The global hematopoietic stem cell transplantation (HSCT) market is divided into: by transplant type, by disease indication, by application and by geography. Transplant type segment of HSCT market was divided into autologous transplant and allogeneic transplant. While allogeneic transplant was further segmented into family related and unrelated transplant. On the basis of disease indication the market was divided into lymphoproliferative disorders, leukemia, non-malignant disorders. On the basis of application the hematopoietic stem cell transplantation (HSCT) market is divided as peripheral blood stem cells transplant (PBSCT), bone marrow transplant (BMT), and cord blood transplant (CBT).
Geographically, the hematopoietic stem cell transplantation (HSCT) market has been segmented into five regions: North America, Europe, Asia Pacific, Europe, Middle East & Africa (MEA), and Latin America. Each regional market for HSCT market has been further categorized into major transplant type, disease indication, and application segments considered within the scope of the study. Key country (U.S., Canada, Japan, Germany, France, U.K., Australia, Canada, China, Brazil, Mexico, India, etc.) market revenues have also been provided in different regional sections within the report.
The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn and market volume in terms of units for the period from 2017 to 2025, along with the compound annual growth rate (CAGR %) from 2017 to 2025) are provided for all segments, considering 2016 as the base year. Market revenue in terms of US$ Mn and volume in terms of units for the period from 2015 to 2025 along with CAGR % from 2016 to 2025 are provided for all the regions and nations considering 2016 as the base year.
Companies Mentioned in the Report
The report profiles key manufacturers in the hematopoietic stem cell transplantation (HSCT) Market based on various attributes such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include Regen Biopharma, Inc., Escape Therapeutics, Inc., Lonza Group Ltd., and Pluristem Therapeutics Inc.
The global hematopoietic stem cell transplantation (HSCT) Market has been segmented as follows:
By Transplant Type
- Family Related
By Disease Indication
- Lymphoproliferative disorders
- Non-malignant Disorders
- Peripheral Blood Stem Cells Transplant (PBSCT)
- Bone Marrow Transplant (BMT)
- Cord Blood Transplant (CBT)
- North America
- Asia Pacific
- Latin America
- Middle East and Africa